| B. Gebauer | Honoria or consultation fees | Parexel/CALYX, C.R. BARD/BD, SIRTex Medical, COOK, AngioDynamics, Pharmcept, Guerbet, Ewimed, Boston Scientific, Terumo, Roche, Merck, 3M, Beacon Bioscience/ICON, IPSEN, Bayer, Pfizer, Elsai, MSD, INARI, Siemens/VARIAN |
| P. Knüsel | Honoria or consultation fees | Boston Scientific |
| C. Kölblinger | No potential conflict of interest | |
| C. Neumann | Grants/research supports | Boston Scientific |
| C. Neumann | Honoraria or consultation fees | Boston Scientific |
| P.M. Paprottka | No potential conflict of interest | |
| G. Puippe | No potential conflict of interest | |
| P. Reimer | No potential conflict of interest | |
| A. Schmid | No potential conflict of interest | |
| M. Schoder | No potential conflict of interest | |
| W. Uller | Participation in a company sponsored speaker’s bureau | BayerVital GmbH, medpublico GmbH |
| C.J. Zech | No potential conflict of interest | |
